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Abstract
Background:  In the context of sickle cell anemia, peripheral blood indexes provide key
information that is also potentially influenced by age. Therefore, it is necessary to understand the
extent and nature of interactions between sickle cell anemia and age, especially in situations where
there is a high prevalence of sickle cell anemia.
Methods: In a cross-sectional study of 374 subjects with varying hemoglobin S (HbS) status, we
characterized the interaction between age and sickle hemoglobin using principal components
analysis.
Results: Factor analysis in subjects with hemoglobin AA identified three orthogonal factors –
normal erythropoiesis, presence of thalassemia and the aggregability potential of the blood. These
three factors were differentially associated with hemoglobin status. Age influenced the association
of factors #2 and #3 with hemoglobin status.
Conclusion: Our findings suggest that the interaction between age and hemoglobin status needs
to be considered in both clinical and public health settings.
Background
Sickle cell disease strongly influences the peripheral blood
cell counts and red cell characteristics. Moreover, each of
these parameters measured in the peripheral blood can be
potentially instructive with regards the systemic altera-
tions in sickle cell pathophysiology. However, since these
peripheral blood indexes show complex correlations
among each other [1,2] it is conceivable that they capture
overlapping information about the disease process and
pose difficulty for correctly interpreting the different and
independent components that are affected in sickle cell
pathology. One study [2] – using data from 825
homozygous sickle cell subjects – used principal compo-
nents analysis and observed that the peripheral blood
characteristics map on to three "factors" that represent
hemolysis rate, presence of β-thalassemia and intra-eryth-
rocytic hemoglobin polymerization. However, since this
study used homozygous sickle cell subjects only, it did not
permit an understanding of the extent to which the factors
are altered in sickle cell anemia as compared to their nor-
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mal configuration. Further, age is known to significantly
affect the peripheral blood characteristics. Therefore, it
becomes of practical as well as academic interest to
explore if age differentially influences these factors.
Methods
We conducted a cross-sectional study on 374 subjects –
196 (52.4%) with hemoglobin AA (HbAA), 97 (25.9%)
with hemoglobin AS (HbAS) and 81 (21.7%) with hemo-
globin SS (HbSS) pattern on cellulose acetate paper elec-
rophoresis at pH 8.4. The subjects were recruited from
Departments of Pathology at two centers in India –
Mahatma Gandhi Institute of Medical Sciences, Wardha
(n = 216) and Indira Gandhi Government Medical Col-
lege, Nagpur (n = 158). The characteristics of subjects
recruited at the Wardha center have been described previ-
ously [3]. In this group of subjects ~69% were males and
none of the studied blood parameters were significantly
different across gender. In the Nagpur center, all the sickle
cell subjects were males. Overall, our study sample was
predominantly male (~82%). The two study centers were
comparable with respect to the level of health care pro-
vided, socioeconomic status of the subjects, diagnostic
protocol for sickle cell disease inclusive of hemoglobin
electrophoresis and measurement of peripheral blood
indexes on an automated cell counter, therapeutic proto-
col for sickle cell disease and the frequency of infectious
disease observed in the sickle cell subjects (data not
shown). There were 196 (52.4%) children (age<12 years),
71 (19.0%) adolescents (age 12 – <18 years) and 107
(28.6%) adults (age ≥ 18 years) in our study sample. The
study protocol was approved by the Ethical Committee of
the Indira Gandhi Government Medical College, Nagpur
and the institutional review board of the Lata Medical
Research Foundation.
We used principal components factor analysis (PCF) to
gain insights into the pathophysiology of sickle cell ane-
mia. This analysis permits the representation of each vari-
able as a linear combination of the latent factors [4] as zij
= Σbikfkj + ui, where z represents the standardized value of
the ith variable for the jth subject, b represents the factor
loading of the ith variable on the kth factor, f represents the
factor score of the kth factor for the jth subject and u repre-
sents the uniqueness of the ith variable. For the purposes
of our analyses, we used PCF on nine variables: red blood
cell count (RBC), hemoglobin concentration (HB),
packed cell volume (PCV), mean corpuscular volume
(MCV), mean corpuscular hemoglobin (MCH), mean cor-
puscular hemoglobin concentration (MCHC), red cell dis-
tribution width (RDW), platelet count (PLT) and total
leukocyte count (TLC).
Our overall analytical strategy was as follows: i) We used
PCF only on the HbAA subjects. We undertook this step
since we first needed to understand the principal compo-
nents derived from normal subjects and second we
needed to see if this derived factor structure is altered in
subjects with the sickle cell gene – either in homozygous
or heterozygous state. Hemoglobin AA genotype repre-
sents the normal non-mutated adult hemoglobin. There-
fore this group of subjects served as the reference group for
deriving the principal components. The PCF solution in
this group of subjects was obtained using a criterion of a
minimum eigenvalue of 1. Then we optimized the factor
solution using varimax rotation. ii) Using the factor struc-
ture so obtained we estimated the factor scores on all sub-
jects including the HbAS and HbSS. In other words we
applied the factor structure of the HbAA subjects to all the
subjects. iii) We then compared the factor scores for each
identified factor across the HbAA, HbAS and HbSS groups
as well as across the different age groups. Our decision to
categorize age was based on the following reasons consid-
ered in unison: a) we wished to examine if particular clin-
ically relevant age groups influenced the factor structure
rather than whether age is a predictor of the factor scores;
b) if age would have been used as a continuous variable
then it would have constrained our analysis around an
implicit assumption of a linear association between factor
scores and age. However, as our age categorization indi-
cates, we had no a priori reason for assuming this linear
relationship; and c) we conducted analysis of variance
using factor scores as the dependent variable and the
sickle cell genotype and age as the predictors. The results
of these analyses indicated (especially for the second fac-
tor score) that the model fit was better when age categories
were used as the predictor. These results (data not shown)
suggested that the assumption of linearity for our dataset
was not valid. iv) We used analysis of variance (ANOVA)
to understand the simultaneous and interacting influence
of age and hemoglobin on the identified factor scores.
Results
Results of PCF analysis
The results of PCF in the HbAA subjects are shown in Fig-
ure 1A and 1B. Our analysis identified three orthogonal
factors. On the first factor, RBC, HB and PCV loaded
strongly positively while RDW loaded strongly negatively
suggesting that this factor represented normal erythropoi-
esis [5]. On the second factor, MCV, MCH and MCHC
loaded strongly negatively raising the possibility that this
factor perhaps related to iron deficiency anemia and/or
thalassemia – two forms of anemia common in the study
setting. However, the fact that the RBC loaded positively
while RDW only minimally loaded on this factor indi-
cated [6] that factor was less likely to be iron deficiency
anemia and we thus named this factor as the thalassemia
factor. On the third factor, PLT and TLC loaded strongly
positively while RDW loaded moderately positively point-
ing towards the possibility that, in the context of sickle cellBMC Blood Disorders 2006, 6:3 http://www.biomedcentral.com/1471-2326/6/3
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anemia, this factor indicated the aggregability potential of
the blood since red cell anisocytosis, leukocytosis and
thrombocytosis are known to increase the blood viscosity
[7] as well as influence the vascular endothelial reactivity
[8]. Together these factors explained ~80% of the variabil-
ity in the nine variables studied.
Assessment of the factor scores
When we examined the factor scores across the age catego-
ries and hemoglobin status of the study subjects (Figure
1C to 1E), we noted several interesting observations. First,
the normal erythropoiesis factor scored significantly low
in the HbSS subjects at all ages. Second, the scores of fac-
tor #1 demonstrated a consistent trend across hemo-
globin status (HbAA>HbAS>HbSS) at all ages. Third, the
thalassemia factor scores were significantly reduced in
HbSS subjects in children but not at higher ages indicating
that the coexistence of thalassemia and sickle cell anemia
is more likely at higher ages. Indeed, when we conducted
ANOVA with an interaction term we observed that the
interaction between age and hemoglobin status was
highly significant (F = 4.17, p = 0.0026) while neither age
nor hemoglobin status significantly predicted the factor
score for the thalassemia factor. Fourth, the increase in the
aggregability potential factor was increased significantly
only in HbAS subjects in adults although a trend (p =
0.15) to an increased aggregability potential was also seen
in children.
Discussion
By its very nature, explorative factor analysis is essentially
a speculative tool. The factors identified and named in a
factor analysis always need to be considered in the light of
the existing knowledge. Consequently, it can not be
claimed that the factor structure obtained within a sample
is completely generalizable. Also, since our sample was
not representative of females, we can not comment about
the influence of gender on our inference. Nevertheless,
what we attempted in the present study is to examine if
factor structure is different across subjects with differing
hemoglobin status and age categories and we found
important differences.
Our results have at least two implications. First, the coex-
istence of thalassemia and sickle cell anemia seems to be
age-related. Again, in the absence of knowledge about the
hemoglobin A2 concentration in the study subjects it will
not be possible to emphatically conclude about the coex-
istence of these two conditions. However, our finding cor-
roborates the fact that the morbidity and mortality of both
thalassemia and sickle cell anemia is more in children [9]
making the detection of coexistence difficult in a study
like ours. By contrast, it can be argued that adults who
have survived both these challenges in childhood are
likely to demonstrate a higher prevalence of these two dis-
orders simultaneously in populations where both the dis-
Results of principal components factor analysis Figure 1
Results of principal components factor analysis. (A 
and B) The factor structure of HbAA study subjects and the 
variability explained by the retained factors. Numbers in 
panel A show the factor loadings. (C to E) Influence of age 
and hemoglobin status on the factor scores for the three fac-
tors shown in panel A. The point and 95% confidence inter-
vals are depicted as markers (diamonds for factor #1, filled 
squares for factor #2 and circles for factor #3) and error 
bars, respectively. The analysis is shown for all combinations 
of age categories and hemoglobin status. For each age cate-
gory and factor the influence of hemoglobin was assessed by 
ANOVA (p values shown at the top). Also, the factor scores 
for HbAS and HbSS subjects were compared with those of 
HbAA subjects for each combination using Mann-Whitney 
test. *, Bonferroni-corrected p < 0.05; ϒ, Bonferroni-cor-
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orders are common. Screening programs for these two
conditions need to be made aware of this possibility. Sec-
ond, the fact that factor #3 showed a higher score in sickle
cell anemia indicates that myeloid hyperplasia in addition
to erythroid hyperplasia can occur in sickle cell disease
especially at higher age. This argument concurs with the
several recent findings that report thrombocytosis as well
as leukocytosis in sickle cell disease [3,10].
Conclusion
On a wider scale, our findings demonstrate the need to
consider age in correctly interpreting peripheral blood
picture in sickle cell anemia.
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